Mercer Global Advisors
OPRX icon

Mercer Global Advisors’s OptimizeRx OPRX Stock Holding History

Mercer Global Advisors’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.5K Buy
13,893
+1,342
+11% +$7.71K ﹤0.01% 3468
2026
Q1 		$78.8K Buy
+12,551
New +$117K ﹤0.01% 3070

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Mercer Global Advisors's OPRX Position: Q2 2026 in Review

Mercer Global Advisors increased its OptimizeRx (OPRX) stake by 11% in Q2 2026, buying an estimated $7.71K and bringing the position to 13,893 shares worth $79.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3468.

Mercer Global Advisors first reported a position in OPRX in Q1 2026 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Mercer Global Advisors held 13,893 shares of OptimizeRx worth $79.5K as of Q2 2026.
  • Mercer Global Advisors bought 1,342 OptimizeRx shares in Q2 2026, an estimated $7.71K.
  • OptimizeRx made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3468 holding.
  • Mercer Global Advisors first reported a position in OptimizeRx in Q1 2026 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.